Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma

Satoru Hagiwara(Kindai University), Toshiharu Sakurai(Kindai University)
British Journal of Cancer
May 17, 2012
Cited by 106


Related Papers